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Recently it has been reported that the estimated glomerular filtration rate (eGFR) is higher in habitual coﬀee consumers than in
noncoﬀee consumers. However, the causality remains unclear. Therefore, we conducted a clinical trial to investigate the eﬀects
of coﬀee consumption on kidney function. Nineteen asymptomatic nonsmokers aged 21–27 years old participated in this study.
They consumed coﬀee (18 g coﬀee beans/450mL per day) or green tea as a comparator for 2 weeks in a crossover design. Although
creatinine-based eGFR was not aﬀected after consuming either beverage, all cystatin-C-based eGFRs determined using five
diﬀerent equations were significantly increased after coﬀee consumption (means: 5.0–7.7%), but not after green tea consumption
(means: 0.1–1.6%). Serum adiponectin andmagnesium levels increased significantly after coﬀee consumption (means: 13.6% and
4.3%, resp.), but not after green tea consumption. These findings suggest that even a short period of coﬀee consumption may
increase cystatin-C-based eGFR, along with favorable changes in serum adiponectin, in healthy young adults.
1. Introduction
Coﬀee is one of the most frequently consumed beverages
worldwide. Habitual coﬀee consumption has been puta-
tively associated with some benefits, including prevention
of type 2 diabetes and cardiovascular diseases [1–5]. In
turn, these disorders show very strong associations with
impaired kidney function. We previously reported that, in
apparently healthy people, habitual coﬀee consumption is
associated with normal or increased estimated glomerular
filtration rate (eGFR) determined based on serum creatinine
levels [6]. This finding was recently supported by a cross-
sectional study of Japanese individuals [7] in which the
authors also found that the association was independent of
inflammation assessed by circulating C-reactive protein and
was independent of sugar consumption. However, because
of the nature of cross-sectional studies, the cause-eﬀect
relationship remains unclear. Therefore, to elucidate the
causality and possible underlying mechanism is of scientific
interest and important in terms of public health, because
the prevalence of chronic kidney disease, including diabetic
nephropathy, is increasing worldwide [8].
Therefore, we conducted a clinical trial to investigate the
eﬀects of coﬀee consumption on kidney function in healthy
young adults. In this study, kidney function was assessed
by eGFR based on the serum creatinine concentration and
on the serum concentration of the low molecular weight
protein cystatin C. The latter is sensitive to kidney function
independently of muscle mass, particularly in people with
mildly impaired kidney function [9–11]. We selected green
tea as a control because it is a common beverage among
Japanese individuals and because green tea consumption has
also been reported to be inversely associated with type 2
diabetes in several studies [2, 4, 5, 12]. It has also been shown
that serum adiponectin increases after coﬀee consumption
[13, 14] and that coﬀee contains plenty of magnesium.
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Therefore, we examined serum adiponectin and magnesium
levels to evaluate these eﬀects on eGFR.
2. Methods
This study was approved by the Ethics Committee of Josai
University and by our departmental ethics committee. We
randomly recruited 19 apparently healthy nonsmokers aged
21–27 years old (8 men and 11 women). They had no self-
reported medical history of cardiovascular diseases or kidney
diseases such as glomerulonephritis. All participants gave
written informed consent.
In April and May 2010, they consumed coﬀee (MJB Basic
Blend, Tokyo, Japan, 18 g coﬀee beans/450mL per day) or
green tea (STANCUP, Tokyo, Japan, 6 g tea leaf/450mL per
day), equivalent to three cups per day, for 14 consecutive
days in a crossover design. Coﬀee and green tea was prepared
using coﬀee machines and tea bags, respectively, at a meeting
room at the university by our staﬀ every morning. Subjects
were given a thermos containing 450mL of coﬀee or green
tea in themorning and drunk it withoutmilk or sugar during
the day. The participants followed an 8-day washout period
before participating in the study and a 7-day washout period
between each intervention. Throughout the study, including
the washout periods, the participants were required to refrain
from exhausting exercise and drinking alcohol, coﬀee, or tea,
other than that provided.
At baseline, the subjects were randomly divided into two
groups. Participants in one group (n = 10, men/women,
5/5) received coﬀee in the first phase and green tea in the
second phase, while the other group (n = 9, men/women,
3/6) received green tea in the first phase and coﬀee in the
second phase.
Anthropometric measurements, blood pressure tests,
and laboratory tests were conducted in the early morning at
the same time of the day. Clinical and biochemical variables
were measured with standard methods using autoanalyzers.
The serum creatinine concentration was measured enzy-
matically (Shika liquid-S, CRE, Kanto Chemical Co., Inc.,
Tokyo, Japan). Serum adiponectin and serum magnesium
were measured using a human adiponectin enzyme-linked
immunosorbent assay (Otsuka Pharmaceutical Co., Ltd.,
Tokyo, Japan) and a colorimetric method (Daiichi Fine
Chemical Co., Ltd., Tokyo, Japan), respectively. Intra-assay
coeﬃcients of variation for creatinine, adiponectin, and
magnesium were <5%, <10%, and <3.0%, respectively.
Serum cystatin C was measured by the latex agglutination
turbidimetry method (Auto Cystatin C-BML Inc., Tokyo,
Japan). The reference range, as described in the manufac-
turer’s instructions, was 0.40–0.91mg/L. According to the
report by Wada et al. [15], who measured serum cystatin
C using the same method used in our study, the intra-assay
and interassay coeﬃcients of variation were 0.55–0.81% and
0.48–1.27%, respectively.
HbA1c was measured in Japan Diabetes Society (JDS)—
HbA1c units by high-performance liquid chromatography.
HbA1c was converted to National Glycohemoglobin Stan-
dardization Program (NGSP) levels by the formula HbA1c
(%) (NGSP) = HbA1c (JDS) (%) + 0.4%, considering the
relational expression of HbA1c (JDS) (%) measured by
the previous Japanese standard substance and measurement
methods [16].
Kidney function, as assessed by eGFR, was calculated
using the following equations. The serum creatinine-based
eGFR was determined based on a modified version of that
used in the Diet in Renal Disease study for Japanese subjects
[17]:
eGFR
(
mL/min/1.73m2
)
= 194× Cr−1.094 × Age−0.287 (if female)× 0.739,
(1)
Cr = serum creatinine concentration (mg/dL).
Serum cystatin-C-based eGFRs were determined accord-
ing to the following equations using serum cystatin C meas-
ured by four particle-enhanced immunoturbidimetric assays
(PETIAs) [18–21] and one particle-enhanced immunoneph-
elometric assay (PENIA) [22]:
(1) eGFR = −6.87 + 87.1/Cys C (Tan et al. [18]),
(2) eGFR = 99.19 × Cys C−1.713× 0.823 (if female)
(Grubb et al. [19]),
(3) eGFR = −22.3 + 124/Cys C (Sjo¨stro¨m et al. [20]),
(4) eGFR = 99.434 × Cys C−1.5837 (Larsson et al. [21]),
(5) eGFR = −4.32 + 80.35/Cys C (Hoek et al. [22])
Cys C = serum cystatin C concentration (mg/L).
In this study, serum cystatin C was measured with a
PETIA method. For a comparative reference, we also in-
cluded eGFR calculated with the PENIA method by Hoek et
al. because the Hoek formula showed the best overall per-
formance for GFR estimation with respect to bias, precision,
and accuracy, as compared with similar methods [22].
Data are expressed as mean ± SD. Changes in variables
after the consumption of both beverages are expressed as
means (95% CI). Statistical diﬀerences in variables between
5 habitual coﬀee consumers and 14 nonhabitual coﬀee
consumers were examined using the Mann-Whitney test.
Diﬀerences in most variables between coﬀee consumption
and green tea consumption and those between before and
at the end of the interventions were examined by paired
t-test and repeated-measures ANOVA for normally dis-
tributed variables determined by the Kolmogorov-Smirnov
test, respectively, or by the Wilcoxon rank test for nonnor-
mally distributed variables. Correlations between changes in
variables were examined by the Pearson correlation tests.
Statistical analysis was performed using IBM-SPSS version
18.0 (SPSS Inc., Chicago, ILL, USA) and Statview version
5.0 (SAS Institute, Cary, NC, USA). Values of P < .05 were
considered statistically significant.
3. Results
None of the subjects reported any adverse eﬀects in response
to consumption of coﬀee or green tea during the study,
resulting in good adherence to the consumption of both
beverages. The clinical characteristics of subjects and serum
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Table 1: Clinical characteristics of subjects.
Mean ± SD
Age (years) 22.3 ± 1.7
Sex (male/female) 8/11
Height (cm) 163 ± 8.6
Body mass index (kg/m2) 21.3 ± 2.5
Systolic blood pressure (mmHg) 120 ± 11.9
Diastolic blood pressure (mmHg) 77 ± 8.8
Total cholesterol (mg/dL) 176 ± 21
High-density lipoprotein cholesterol
(mg/dL)
68.7 ± 15.1
Triglycerides (mg/dL) 69.2 ± 37.5
Blood glucose (mg/dL) 85.6 ± 7.2
HbA1c (%, NGSP) 5.1 ± 0.2
HbA1c (mmol/mol, IFCC) 37 ± 2
Uric acid (mg/dL) 5.2 ± 1.3
Blood urea nitrogen (mg/dL) 14.5 ± 3.2
Creatinine (mg/dL) 0.71 ± 0.17
Creatinine-based eGFR (mL/min per
1.73m2)
101 ± 16.5
Cystatin C (mg/L) 0.81 ± 0.13
Magnesium (mg/dL) 2.3 ± 0.2
Adiponectin (µU/mL) 10.6 ± 4.7
Habitual coﬀee consumption, n (%) 5 (26.3)
Habitual tea consumption, n (%) 7 (36.8)
Habitual alcohol consumption, n (%) 3 (15.8)
NGSP; National Glycohemoglobin Standardization Program, IFCC; Inter-
national Federation of Clinical Chemistry and Laboratory Medicine.
Habitual coﬀee, green tea, and alcohol consumers were defined as subjects
who drink one or more cups of coﬀee or green tea and those who drink
alcohol everyday, respectively.
variables at baseline, after the 8-day washout period, are
shown in Table 1. Overall, the subjects had favorable profiles
for all characteristics that were within normal ranges. There
were no significant diﬀerences in any of the variables between
5 habitual coﬀee consumers and 14 nonhabitual coﬀee
consumers. Table 2 shows the diﬀerence in variables between
the start and the end of each intervention phase. Data before
and after each treatment phase from two groups were pooled
for each treatment. Serum creatinine levels were not altered
after either intervention; also, creatinine-based eGFRwas not
aﬀected by either beverage. In contrast, serum cystatin C
was significantly decreased after coﬀee consumption (mean:
−4.8%, P = .002, one-way repeated-measure ANOVA), but
not after green tea consumption (mean: −1.3%). Serum
adiponectin and magnesium levels increased after coﬀee
consumption (means: 13.6% and 4.3%, resp.). By contrast,
systolic blood pressure and blood glucose were signifi-
cantly reduced by green tea consumption, whereas serum
adiponectin and magnesium levels did not significantly
increase after green tea consumption. Of note, a significant
reduction in HbA1c was observed after both interventions.
Table 3 shows the diﬀerence in cystatin-C-based eGFRs
calculated using five diﬀerent equations between the start
and the end of each intervention phase. Although cystatin-
C-based eGFRs varied widely, all cystatin-C-based eGFRs
increased significantly after coﬀee consumption (means: 5.0–
7.7%), but not after green tea consumption (means: 0.1–
1.6%). Nevertheless, the cystatin-C-based eGFRs at baseline
before coﬀee consumption were significantly lower than
those at baseline before green tea consumption (all P <
.05). As shown in Table 4, the changes in cystatin-C-
based eGFRs determined using five diﬀerent equations were
significantly correlated with changes in serum magnesium
concentration after coﬀee consumption, but not after green
tea consumption. There were no significant correlations
between changes in serum cystatin-C and changes in other
variables for both beverages (data not shown). Figure 1
summarizes the diﬀerence in variables between the start and
the end of each intervention phase, according to the beverage
consumed.
4. Discussion
Coﬀee and green tea have been reported to have putatively
protective eﬀects against type 2 diabetes and cardiovascular
diseases [2, 4, 5]. However, the underlying mechanisms
remain unclear. To date, few studies have addressed the
eﬀects of these beverages or caﬀeine-containing beverages
in general on kidney function [24], a key risk factor for
cardiovascular diseases. In this study, we showed that coﬀee
consumption for 2 weeks reduced cystatin-C and increased
cystatin-C-based eGFR in apparently healthy young adults.
Furthermore, the levels of serum adiponectin and magne-
sium were significantly increased after coﬀee consumption.
Nevertheless, these eﬀects of coﬀee consumption were not
observed with green tea consumption.
Interestingly, these increases in eGFR after coﬀee con-
sumption were not apparent after green tea consumption.
This may be attributable to unintended bias because the
eGFRs assessed using either creatinine and cystatin C were
actually lower before coﬀee consumption than before green
tea consumption. Nevertheless, we are unable to directly
compare the eﬀects of coﬀee consumption with those of
green tea consumption because the green tea dose equivalent
to coﬀee beans is not validated and needs to be determined in
terms of kidney function. Furthermore, comparison of coﬀee
with green tea per se was not our main purpose in this study.
Although the current findings suggest that coﬀee con-
sumption seems to influence kidney function, the increased
cystatin-C-based eGFR does not necessarily reflect improved
kidney function. The subjects in this study had normal eGFR
at baseline, and an increased eGFR might reflect glomerular
hyperfiltration, which is often observed in obese people
[25, 26] or at early stage of diabetic nephropathy [27].
To fully address whether the current findings are favorable
and protective of kidney function, longitudinal prospective
studies of coﬀee consumers are needed.
The increased adiponectin concentration after coﬀee
consumption in the present study is consistent with previous
reports [13, 14]. However, it is unlikely that the increased
adiponectin levels directly contributed to the increase in
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Table 2: Changes in variables according to coﬀee and green tea consumption.
Coﬀee Green tea
Baseline
End of
consumption
Change (95% CI) Baseline
End of
consumption
Change (95% CI)
BMI (kg/m2) 21.2 ± 2.5 21.3 ± 2.4 0.1 (0.0–0.2) 21.4 ± 2.5 21.2 ± 2.5 −0.2 (−0.3–0.0)
SBP (mmHg) 118 ± 16 119 ± 11 0.7 (−5.9–7.4) 121 ± 11 116 ± 9.3∗ −0.5 (−9.6–−0.3)
DBP (mmHg) 75 ± 8.8 77 ± 9.1 2.5 (−1.2–6.2) 78 ± 8.9 76 ± 7.4 −1.7 (−6.9–3.4)
Total cholesterol
(mg/dL)
174 ± 22 175 ± 26 1.7 (−5.1–8.6) 176 ± 19 170 ± 22 −5.4 (−12.5–1.7)
HDL-cholesterol
(mg/dL)
66 ± 15 67 ± 14 0.6 (−2.6–3.7) 65 ± 13 66 ± 13 0.4 (−2.2–3.1)
Triglycerides (mg/dL) 70 ± 33 86 ± 52 16.4 (−2.8–35.7) 79 ± 38 72 ± 46 −6.3 (−25.5–12.9)
Blood glucose
(mg/dL)
84 ± 10 84 ± 9.4 0.1 (−5.1–5.3) 87 ± 5.6 84 ± 7.9∗ −3.4 (−6.8–−0.1)
HbA1c (%, NGSP) 5.1 ± 0.2 5.0 ± 0.2∗,a −0.1 (−0.1–0.0) 5.1 ± 0.2 5.0 ± 0.2∗ −0.1 (−0.1–0.0)
Uric acid (mg/dL) 5.2 ± 1.2 5.2 ± 1.1 0.1 (−0.2–0.3) 5.1 ± 1.1 5.1 ± 1.3 0.0 (−0.3–0.2)
Blood urea nitrogen
(mg/dL)
14.3 ± 3.3 13.6 ± 2.7 −0.7 (−2.1–0.7) 13.6 ± 3.4 13.1 ± 3.2 −0.5 (−2.1–1.2)
Serum creatinine
(mg/dL)
0.72 ± 0.16† 0.72 ± 0.17 0.00 (−0.02–0.02) 0.70 ± 0.15 0.71 ± 0.17 0.01 (−0.01–0.02)
Creatinine
based-eGFR
(mL/min/1.73m2)
99.6 ± 16.4 99.6 ± 16.6 0.0 (−3.4–3.4) 102.0 ± 15.9 102.0 ± 19.0 0.1 (−2.9–3.0)
Serum cystatin C
(mg/L)
0.83 ± 0.12† 0.79 ± 0.10∗∗ −0.04 (−0.06–−0.02)† 0.79 ± 0.12 0.79 ± 0.12 −0.01 (−0.03–0.02)
Magnesium (mg/dL) 2.3 ± 0.1 2.4 ± 0.2∗,† 0.1 (0.0–0.1) 2.3 ± 0.1 2.3 ± 0.2 0.0 (0.0–0.1)
Adiponectin (µg/mL) 11.0 ± 4.7 12.5 ± 5.3∗∗ 1.5 (0.6–2.4) 10.5 ± 4.6 11.7 ± 5.0 1.1 (−0.6–2.9)
Data are expressed as means ± SD. Changes in variables are expressed as means (95% CI).
∗P < .05, ∗∗P < .01, End of consumption versus baseline (repeated ANOVA), †P < .05, versus green tea (Paired t-test).
a diﬀerence was examined by Wilcoxon rank test because normal distribution was not confirmed.
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL: high-density lipoprotein, eGFR: estimated glomerular filtration rate.
Table 3: Diﬀerence in cystatin-C-based eGFR (determined using five diﬀerent equations) between the start and end of each consumption
period.
Cystatin-C-based eGFR Coﬀee Green tea
(mL/min/1.73m2) Baseline
End of
consumption
P
value
Change
(95% CI)
Baseline
End of
consumption
P value
Change
(95% CI)
Tan et al. [18] PETIA 101 ± 15.8† 106 ± 14.4 .01 5.1 (1.3–8.9)† 105 ± 17.1 106 ± 17.9 .51 1.1 (−2.4–4.6)
Grubb et al. [19] PETIA 128 ± 27.0† 137 ± 21.6 .02 9.9 (1.8–18.0) 137 ± 28.6 139 ± 31.3 .50 2.4 (−5.0–9.9)
Sjo¨stro¨m et al. [20] PETIA 131 ±22.5† 138 ± 20.4 .01 7.2 (1.8–12.7)† 137 ± 24.4 139 ± 25.5 .51 1.6 (−3.4–6.5)
Larsson et al. [21] PETIA 140 ± 33.1† 150 ± 30.2 .02 10.3 (1.8–18.8)† 150 ± 36.0 152 ± 38.3 .50 2.4 (−5.1–10.0)
Hoek et al. [22] PENIA 94.9 ± 14.6† 99.5 ± 13.2 .01 4.7 (1.1–8.2)† 99.2 ± 15.8 100 ± 16.5 .51 1.0 (−2.1–4.2)
P values were determined by repeated-measure ANOVA. †P < .05 versus green tea (paired t test).
eGFR because we found no significant correlation between
changes in cystatin-C-based eGFR and changes in serum
adiponectin levels. Furthermore, blood glucose and HbA1c
were not associated with parameters related to kidney
function, suggesting that changes in cystatin C-based eGFR
may be independent of glucose metabolism. Nevertheless,
the short duration of this study may conceal the intrinsic
eﬀects of coﬀee consumption on kidney function and clinical
variables.
The kidney is known to play a critical role in magne-
sium homeostasis and in maintaining plasma magnesium
concentrations [28]. In this study, the increase in serum
magnesiummay reflect the absorption of nutrients present in
coﬀee into the blood or increased magnesium reabsorption
by the kidney. Several studies have reported inverse associa-
tions between serum magnesium concentrations and insulin
resistance [29, 30]. Thus, although changes in cystatin C-
based eGFRs were significantly correlated solely with those in
serum magnesium in this study, it remains unclear whether
the increased magnesium concentration directly modified
the kidney function. It is possible that other bioactive
constituents of coﬀee that were not examined in this study,
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Table 4: Correlation coeﬃcients between changes in cystatin-
C-based eGFR (determined using five diﬀerent equations) and
changes in serum magnesium between the start and end of each
consumption period.
Cystatin C-based
eGFR
Coﬀee Green tea
r P value r P value
Tan et al. 0.47 .04 0.08 .75
Grubb et al. 0.48 .04 0.10 .68
Sjo¨stro¨m et al. 0.47 .04 0.08 .75
Larsson et al. 0.49 .03 0.09 .75
Hoek et al. 0.47 .04 0.08 .75
Correlation coeﬃcients were examined by the Pearson correlation tests.
such as major chlorogenic acid and phenolic acids, may
contribute to this phenomenon. van Dijk et al. [31] provided
evidence that chlorogenic acid and trigonelline reduced
early glucose and insulin responses during a 2-hour oral
glucose tolerance test in 15 overweight men. In addition,
it is possible that chlorogenic acid improves postprandial
glucosemetabolism by reducing glucose uptake or increasing
glucagon-like peptide-1 levels [32, 33]. This may explain why
HbA1c, which reflects overall glucose homeostasis, but not
blood glucose levels, was significantly improved following
coﬀee consumption. However, in this study, HbA1c was
also improved following green tea consumption, which is
consistent with the findings of earlier studies [34, 35]. In
this context, the mechanism by which coﬀee consumption
improves HbA1c may diﬀer from that involved in the eﬀects
of green tea.
Kempf et al. [14] reported that coﬀee consumption
increased the concentrations of phenolic acids in the blood
and reduced inflammatory markers, particularly in subjects
with insulin resistance. Thus, these anti-inflammatory eﬀects
may also modify kidney function. Meanwhile, these possible
mechanisms may be consistent with clinical findings that
demonstrate the inverse relationship between coﬀee con-
sumption and serum uric acid [36, 37], because serum uric
acid is mostly excreted by the kidney.
Finally, caﬀeine, which is present in higher concentra-
tions in a cup of coﬀee than in green tea [1], may also aﬀect
kidney function by antagonizing adenosine receptors and
inhibiting phosphodiesterases [24, 38]. However, the acute
eﬀects of caﬀeine intake, particularly diuresis, are unlikely to
be involved in the findings reported here because participants
refrained from drinking coﬀee or green tea in the morning
before laboratory test. Trials using decaﬀeinated coﬀee will
reveal the eﬀects of caﬀeine on eGFR.
Regarding the discrepancy between serum creatinine and
serum cystatin C levels, the most plausible explanation is
that serum cystatin C may be more sensitive to early changes
in kidney function independently of muscle mass [10, 11].
However, in recent years, it has become acknowledged that
the cystatin C level may be aﬀected by factors other than
kidney function, including sex, race, obesity, greater height,
current cigarette smoking, thyroid function, inflammation,
Coﬀee
consumption
Creatinine-based eGFR→ Creatinine-based eGFR→
Serum Cystatin C ↓ Serum Cystatin C ↓
Cystatin C-based eGFRs ↑
Serum adiponectin ↑
Serum magnesium ↑
HbA1c ↓
Green tea
consumption
Cystatin C-based eGFRs→
Serum adiponectin→
Serum magnesium→
HbA1c ↓
Serum creatinine→ Serum creatinine→
Blood glucose→
Systolic blood pressure→
Blood glucose ↓
Systolic blood pressure ↓
Figure 1: Summary of changes in variables according to coﬀee
consumption and green tea consumption.
glucocorticoid function, and malignancy [9, 10, 39–41].
In this study, the subjects were young, nonobese, and
nonsmokers without any critical diseases. Therefore, it is
unlikely that these factors interfered with the outcomes of
serum cystatin C, only after coﬀee consumption. However,
the eﬀects of coﬀee consumption on thyroid hormone and
glucocorticoid hormone activities are still unclear. Further-
more, it is possible that kidney function as well as cystatin
C metabolism (synthesis in cells and extrarenal elimination)
might be changed by coﬀee consumption.
5. Limitations
First, we did not evaluate kidney function using standard
GFR measurements, such as urinary clearance of insulin, the
gold standard method, or two alternative protocols, namely
urinary clearance of iothalamate and plasma clearance of
iohexol [42]. Thus, precise evaluation of GFR is needed
to determine the eﬀects of coﬀee consumption on kidney
function. Second, the change in cystatin C following coﬀee
consumption was 0.04 (mg/L), which is small compared
with the baseline cystatin C levels. However, the change in
serum cystatin C was equivalent to changes in cystatin C-
based eGFR of 4.7–10.3mL/min/1.73m2 (Table 3). Serum
cystatin C appears to be a sensitive parameter that can detect
mild GFR reductions of between 60 and 90mL/min/1.73m2
rather than moderate to severe reductions in GFR [9]. In
addition, cystatin C has been evaluated for the early diagnosis
of acute kidney injury [41]. Taken together, even small
changes in serum cystatin C levels might reflect altered
kidney function, although further studies are needed to elu-
cidate the clinical relevance of such small changes in serum
cystatin C. Third, the short duration of each intervention
and the short washout period possibly interfered with the
outcomes. Finally, because this trial was conducted in healthy
young adults with normal eGFR, the findings may not be
applicable to the general population or people with impaired
kidney function or cardiovascular diseases.
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6. Conclusion
We found that coﬀee consumption for 2 weeks decreased
the serum cystatin C concentration and increased cystatin-
C-based eGFR, along with favorable increases in serum
adiponectin and magnesium concentrations in healthy
young adults. Further studies with a larger study population,
longer intervention time, longer washout periods, and
measured GFR are needed to confirm the current findings
and to address the underlying mechanisms.
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